{
  "docId": "019de073-7087-77cd-a846-97dda09bac98",
  "docSlug": "031593eaf739f40f0f0c49214c912ed3",
  "documentTitle": "9 Meters Biopharma | Investor Presentation Deck | 30 slides",
  "authorId": "9-meters-biopharma",
  "authorName": "9 Meters Biopharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 30,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a pyramid diagram to illustrate the patient population spectrum for SBS.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-7087-77cd-a846-97dda09bac98/14",
  "deckHref": "/decks/019de073-7087-77cd-a846-97dda09bac98",
  "deckJsonHref": "/decks/019de073-7087-77cd-a846-97dda09bac98.json",
  "deckAnchorHref": "/decks/019de073-7087-77cd-a846-97dda09bac98#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.6,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "A solution for SBS patients across the spectrum of disease",
      "attrs": null,
      "subkind": "pyramid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b4c3859-54f7-407c-88a4-096930a2971c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.07,
        "y": 0.33
      },
      "kind": "list",
      "text": "Rapid and Sustained reductions in TSO\nRapid and sustained reductions in PS\nExcellent safety and tolerability\nImproved QoL due to lower administration burden and improved nutrient absorption\nFixed dosing every 2 weeks (Q2W) in a pre-filled syringe (50mg)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6b5c022-ee31-4a1e-877e-afae9649f037",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.07,
        "y": 0.258
      },
      "kind": "paragraph",
      "text": "Long-Acting GLP-1 Slowing Gut Motility and Restoring Nutrient Absorption",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4ad50d0-d55e-4ea3-a7c6-4ee9ab232b0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.07,
        "y": 0.78
      },
      "kind": "source-note",
      "text": "*Vurolenatide remains investigational and under development. Adapted from Jeppesen, P. Expert Opinion on Orphan Drugs. 2013",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1196aa74-6ab4-46d5-b0e0-0e17ef548461",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.08,
        "y": 0.1
      },
      "kind": "title",
      "text": "Vurolenatide target product profile*",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fb20957-8f54-4c81-b44b-3e7a56bee3d0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "204d699d-c969-4389-a0e4-5259c74f431b",
      "evidence": "Rapid and Sustained reductions in TSO, Rapid and sustained reductions in PS, Excellent safety and tolerability, Improved QoL due to lower administration burden and improved nutrient absorption",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "pyramid",
      "slug": null,
      "matchId": "e81f8a8f-e435-4030-9ee6-4efbe43ce0a8",
      "evidence": "The diagram illustrates the spectrum of SBS patients using a triangular hierarchy.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}